IFIH1 and antisynthetase syndrome: DM is recognized to be a heterogeneous disease, which is associated with MSAs and possibly consists of distinct disease entities such as antisynthetase syndrome (ASS), anti-MDA5-positive DM, and cancer-associated DM.